Align Alr3027 protein, component of The 2-oxo monocarboxylate transporter (Pernil et al., 2010). Transports pyruvate which is inhibited by various 2-ketoacids (characterized)
to candidate WP_010441630.1 G7G_RS0111790 TRAP transporter large permease subunit
Query= TCDB::Q8YSQ7 (445 letters) >NCBI__GCF_000192475.1:WP_010441630.1 Length = 435 Score = 328 bits (841), Expect = 2e-94 Identities = 169/441 (38%), Positives = 267/441 (60%), Gaps = 8/441 (1%) Query: 3 LAYEWLGPVMFAGALVLLSSGYPVAFSLGGVAILFGLLGIGLGVFDPIFLTAMPQRIFGI 62 ++ E + + F +L G PVAF LGG A+LF L VF+P L ++P + Sbjct: 1 MSLELITALYFLILFGILFMGLPVAFGLGGTAVLFAL------VFEPRALLSVPSAFYST 54 Query: 63 MANYTLLAIPYFIFMGAMLEKSGIAERLLETMGILLGRLRGGLALAVVLVGALLAATTGV 122 N L+ +P F+FMG+++ SGIAE + + L+G + GGLA+ V V + AA TG+ Sbjct: 55 PWNSVLVTVPLFLFMGSLIRFSGIAETAYDAVYKLIGHIHGGLAMGTVQVCTVFAAITGI 114 Query: 123 VAATVVAMGLISLPIMLRYGYNKELATGVIAASGTLGQIIPPSVVLVVLGDQLGISVGDL 182 MG I+ P M+RY Y++ +A G IAA G LG +IPPSV + G +S+GDL Sbjct: 115 TPPATTTMGQIAYPSMMRYKYDRRIAIGCIAAGGALGALIPPSVPFIFYGLLAKVSIGDL 174 Query: 183 FIGSVIPGLMMASAFALHVLIVAFIRPDVAPALPAQVREIGGKALGKRVIQVMIPPLILI 242 F+ ++PGLM+A+ + +++ + I+P++ PALPA + + L + + P +LI Sbjct: 175 FMAGLLPGLMLATFYTIYIGVRCKIQPELGPALPADQKFTRAEKL--TAVLSIWPFALLI 232 Query: 243 LLVLGSIFFGFATPTEAGAVGCAGAIALAAANGQFTLESLRQVCDTTLRITSMVVFILIG 302 ++VLG I+ G ATP EA A G AGA + G+ T E L++ +TL+++ M ++ILIG Sbjct: 233 IIVLGVIWGGIATPAEAAAFGAAGAFVINLIYGKLTWEVLKESLVSTLKLSGMGLWILIG 292 Query: 303 STAFSLVFRGLNGDQFMFDVLANLPGGKIGFLFVSMTTVFLLGFFIDFFEIAFIVIPLFV 362 +T + VF L + +++ ++PGG G L + M + +LG +D + I + PLF+ Sbjct: 293 ATVYLNVFNTLGSQDLLTNLVLSMPGGSTGILLMMMLIILVLGMVMDDWAIIMLCTPLFI 352 Query: 363 PVAQKLGIDLVWYGVILGANLQTSFLTPPFGFALFYLRGVAPPEVTTSDIYRGVIPFILL 422 P+ +LGID +W+G + N+Q ++LTPPFGF LF+++GV P +V+ D+Y V PF++L Sbjct: 353 PIIDELGIDKLWFGALFIVNIQIAYLTPPFGFVLFWIKGVLPKDVSMGDVYNSVGPFVVL 412 Query: 423 QLLVLLLIIIFPGIVSFLPSL 443 Q + L LI IFP I ++LPS+ Sbjct: 413 QFVGLTLIFIFPQIATWLPSI 433 Lambda K H 0.331 0.149 0.437 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 538 Number of extensions: 20 Number of successful extensions: 3 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 445 Length of database: 435 Length adjustment: 32 Effective length of query: 413 Effective length of database: 403 Effective search space: 166439 Effective search space used: 166439 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 15 ( 7.2 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 40 (21.8 bits) S2: 51 (24.3 bits)
This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory